These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 29669754)
21. B-cell antigen receptor signaling in chronic lymphocytic leukemia: therapeutic targets and translational opportunities. Hill RJ; Lou Y; Tan SL Int Rev Immunol; 2013 Aug; 32(4):377-96. PubMed ID: 23886341 [TBL] [Abstract][Full Text] [Related]
22. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity. Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322 [TBL] [Abstract][Full Text] [Related]
23. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors. Mato A; Jauhari S; Schuster SJ Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792 [TBL] [Abstract][Full Text] [Related]
24. The B-cell receptor pathway: a critical component of healthy and malignant immune biology. Zhong Y; Byrd JC; Dubovsky JA Semin Hematol; 2014 Jul; 51(3):206-18. PubMed ID: 25048784 [TBL] [Abstract][Full Text] [Related]
25. Functional studies of chronic lymphocytic leukemia B cells expressing β Uzonyi B; Mácsik-Valent B; Lukácsi S; Kiss R; Török K; Kremlitzka M; Bajtay Z; Demeter J; Bödör C; Erdei A Immunol Lett; 2017 Sep; 189():73-81. PubMed ID: 28577901 [TBL] [Abstract][Full Text] [Related]
26. B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR. Casey SC; Nelson EL; Turco GM; Janes MR; Fruman DA; Blumberg B Mol Endocrinol; 2011 Jun; 25(6):933-43. PubMed ID: 21436254 [TBL] [Abstract][Full Text] [Related]
27. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia. Stevenson FK; Forconi F; Packham G Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780 [TBL] [Abstract][Full Text] [Related]
28. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. Contri A; Brunati AM; Trentin L; Cabrelle A; Miorin M; Cesaro L; Pinna LA; Zambello R; Semenzato G; Donella-Deana A J Clin Invest; 2005 Feb; 115(2):369-78. PubMed ID: 15650771 [TBL] [Abstract][Full Text] [Related]
38. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579 [TBL] [Abstract][Full Text] [Related]
39. Drug sensitivity and sphingolipid metabolism in CLL. Jaeger U Blood; 2012 Nov; 120(19):3865-6. PubMed ID: 23144156 [No Abstract] [Full Text] [Related]
40. A structural platform for B cell receptor signaling. Xie W; Wucherpfennig K; Patel DJ Cell Res; 2023 Feb; 33(2):95-96. PubMed ID: 36109597 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]